Monomeric Solution Structure of the Prototypical ‘C' Chemokine Lymphotactin,

E. Sonay Kulolu,§ Darrell R. McCaslin, Moiz Kitabwalla, C. David Pauza, John L. Markley,# and Brian F. Volkman*
Department of Biochemistry, Biophysics Instrumentation Facility, and National Magnetic Resonance Facility at Madison, University of WisconsinMadison, 433 Babcock Drive, Madison, Wisconsin 53706, Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, and Institute of Human Virology, University of Maryland, 725 West Lombard Street, Baltimore, Maryland 21201
Biochemistry, 2001, 40 (42), pp 12486–12496
DOI: 10.1021/bi011106p
Publication Date (Web): September 27, 2001
Copyright © 2001 American Chemical Society

 The study was supported by NIH Grant R01 AI45843. For all multidimensional NMR experiments, this study made use of the National Magnetic Resonance Facility at Madison (NMRFAM), using equipment purchased with funds from the University of Wisconsin, the NSF Biological Instrumentation Program (DMB-8415048), the NIH Biomedical Research Technology Program (RR02301), the NSF Academic Research Instrumentation Program (BIR-9214394), the NIH Shared Instrumentation Program (RR02781 and RR08438), and the U.S. Department of Agriculture. Sedimentation equilibrium data were obtained at the University of Wisconsin−Madison Biophysics Instrumentation Facility, which is supported by the University of Wisconsin−Madison and Grants BIR-9512577 (NSF) and S10 RR13790 (NIH).

,

 Coordinates for the minimized average structure and the family of 20 structures have been deposited in the RCSB Protein Data Bank under codes 1J9O and 1J8I, respectively. Chemical shifts have been deposited in the BioMagResBank under accession number 5042.

,
§

 Department of Biochemistry, University of Wisconsin−Madison.

,

 Department of Biochemistry and Biophysics Instrumentation Facility, University of Wisconsin−Madison.

,

 Institute of Human Virology, University of Maryland.

,
#

 Department of Biochemistry and National Magnetic Resonance Facility at Madison, University of Wisconsin−Madison.

,
*

 To whom correspondence should be addressed. Phone:  (414) 456-8400, fax:  (414) 456-6510, email:  bvolkman@mcw.edu.

,

 Department of Biochemistry, Medical College of Wisconsin.

Abstract

Lymphotactin, the sole identified member of the C class of chemokines, specifically attracts T lymphocytes and natural killer cells. This 93-residue protein lacks 2 of the 4 conserved cysteine residues characteristic of the other 3 classes of chemokines and possesses an extended carboxyl terminus, which is required for chemotactic activity. We have determined the three-dimensional solution structure of recombinant human lymphotactin by NMR spectroscopy. Under the conditions used for the structure determination, lymphotactin was predominantly monomeric; however, pulsed field gradient NMR self-diffusion measurements and analytical ultracentrifugation revealed evidence of dimer formation. Sequence-specific chemical shift assignments were determined through analysis of two- and three-dimensional NMR spectra of 15N- and 13C/15N-enriched protein samples. Input for the torsion angle dynamics calculations used in determining the structure included 1258 unique NOE-derived distance constraints and 60 dihedral angle constraints obtained from chemical-shift-based searching of a protein conformational database. The ensemble of 20 structures chosen to represent the structure had backbone and heavy atom rms deviations of 0.46 ± 0.11 and 1.02 ± 0.14 Å, respectively. The results revealed that human lymphotactin adopts the conserved chemokine fold, which is characterized by a three-stranded antiparallel β-sheet and a C-terminal α-helix. Two regions are dynamically disordered as evidenced by 1H and 13C chemical shifts and {15N}-1H NOEs:  residues 1−9 of the amino terminus and residues 69−93 of the C-terminal extension. A functional role for the C-terminal extension, which is unique to lymphotactin, remains to be elucidated.

Tools

Accession Codes

History

  • Published In Issue October 23, 2001
  • Received May 30, 2001
    Revised Manuscript Received July 23, 2001

Recommend & Share